NCL Training Hub

Event Recap: Community Pharmacy Training - March Session

26 March 2025

Paxlovid® (nirmatrelvir/ritonavir) is antiviral used for the treatment of COVID-19 infections. NICE TA878 recommends it as treatment option for specific patient cohorts, with these due to be expanded from 1st June 2025.

Within NCL the primary care based Covid Medicines Delivery Unit assess patients for eligibility and treatment. Currently the dispensing of Paxlovid® is provided by six pharmacies across NCL via the local commissioned Covid-19 Oral Antiviral Medication Supply Service. This service is due to be decommissioned on the 1st April 2025, with the arrangements being transferred to a business as usual model.

To help pharmacists prepare for the transition, the ICB are hosting training sessions which will focus on patient eligibility, potential drug interactions and how to manage them and other guidance to help pharmacists dispense Paxlovid® confidently.

The below recording and slides are from a session that took place on Tuesday 11 March 2025.

Session Slides

Expression of Interest - London Region Teach and Treat Programme

The London Teach and Treat Collaborative are delighted to introduce the London Region Teach and Treat Programme, a new funded initiative designed to build prescribing and supervision capacity in the community pharmacy sector.

16th April 2025

News item

ELC Programme: lunch & learn sessions

Free 60 minute lunch and learn sessions, that offer an opportunity to learn from peers who are pioneering group clinics in primary care practices and specialist services.

16th April 2025

News item

Sign Up Now: For the next NCL supervision support programme workshops

Registration is now open for the next in-person workshops taking place across all NCL boroughs, designed to help practices improve their team’s skills, support clinical supervision, and promote effective multidisciplinary working.